Contract Number: 75f40119c10108
The FDA plans to acquire licenses and services from Synchrogenix Information Strategies Inc. This includes activities required for maintaining and supporting the Global Submit Review and GlobalSubmit Validate software.
The software is being used by reviewers in the CDER and CBER.
The contract value is $1.86M.
[related-post]
FORUM is proud to partner with Philips for a series of articles on their groundbreaking innovations in health technology that serve public- and private sector citizens and service members. Please take a look to learn more about how Philips is advancing modern and efficient health care, while improving lives for generations to come.
